GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sharecare Inc (NAS:SHCR) » Definitions » Peter Lynch Fair Value

Sharecare (Sharecare) Peter Lynch Fair Value : N/A (As of May. 02, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sharecare Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Sharecare's Peter Lynch Fair Value or its related term are showing as below:



SHCR's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.32
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Sharecare Peter Lynch Fair Value Historical Data

The historical data trend for Sharecare's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharecare Peter Lynch Fair Value Chart

Sharecare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
- - - - -

Sharecare Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sharecare's Peter Lynch Fair Value

For the Health Information Services subindustry, Sharecare's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sharecare's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sharecare's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Sharecare's Price-to-Peter-Lynch-Fair-Value falls into.



Sharecare Peter Lynch Fair Value Calculation

Sharecare's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *-0.1
=N/A

Sharecare's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.10.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Sharecare  (NAS:SHCR) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Sharecare's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.7252/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sharecare Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Sharecare's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sharecare (Sharecare) Business Description

Traded in Other Exchanges
Address
255 East Paces Ferry Road NE, Suite 700, Atlanta, GA, USA, 30305
Sharecare Inc is a digital healthcare platform company that helps members consolidate and manage various components of their health in one place, regardless of their health journey. Its platform offers an accessible, interactive, personalized, and rewarding environment that aims to transform user engagement with healthcare from episodic to every day. The platform provides a single destination for people, patients, and caregivers to access quality and clinically reviewed content; digitally connect with other patients, community members, and healthcare professionals; and adopt action plans provided by healthcare professionals from top institutions.
Executives
Brent D Layton director 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63130
Michael Blalock officer: Chief Accounting Officer C/O SHARECARE, INC., 255 E. PACES FERRY RD. NE, SUITE 700, ATLANTA GA 30305
Carrie Ratliff officer: Chief Legal Officer C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Jaffry Mohammed officer: Chief Operating Officer C/O SHARECARE, INC., 255 E. PACES FERRY RD. NE, SUITE 700, ATLANTA GA 30305
Jeffrey Sagansky director 1450 2ND STREET, SUITE 247, SANTA MONICA CA 90401
Kenneth R Goulet director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Sandro Galea director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Veronica Mallett director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
John Huston Chadwick director, other: Affiliate of 10% owner C/O CLARITAS CAPITAL, 30 BURTON HILLS BOULEVARD, SUITE 100, NASHVILLE TN 37215
Jeffrey A Allred director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Alan G. Mnuchin director 2121 AVENUE OF THE STARS, SUITE 2300, LOS ANGELES CA 90067
Jeffrey T Arnold director, 10 percent owner, officer: CEO and Chairman C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Dawn Whaley officer: President, CMO C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Justin Ferrero officer: President, CFO C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Claritas Sc Bactes Partners, Llc other: Affiliate of 10% Owner 30 BURTON HILLS BOULEVARD, SUITE 100, NASHVILLE TN 37215